Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.15 USD
Change Today 0.00 / 0.00%
Volume 638.9K
PPHM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - peregrine pharmaceuticals (PPHM)

Name (Connections)Board RelationshipsTitleKey Developments
Carlton Johnson Jr. 10 RelationshipsChairman, Chairman of Audit Committee, Member of Nominating Committee and Member of Compensation CommitteePeregrine Pharmaceuticals announced delayed annual 10-K filing
07/30/02
Eric Swartz 7 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating Committee 
David Pohl 18 RelationshipsIndependent Director, Chairman of Nominating Committee, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - peregrine pharmaceuticals (PPHM)

Name (Connections)Board RelationshipsTitle
Carlton Johnson Jr. 10 RelationshipsChairman, Chairman of Audit Committee, Member of Nominating Committee and Member of Compensation Committee
David Pohl 18 RelationshipsIndependent Director, Chairman of Nominating Committee, Member of Audit Committee and Member of Compensation Committee
Eric Swartz 7 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating Committee
PPHM Compensation vs. Industry
517.2K
355.7K
Chief Executive Officer
388.0K
263.6K
Chief Financial Officer
Share price activity for PEREGRINE PHARMACEUTICALS (PPHM)
52 Week Price Performance
PPHM
Industry Average

Nominating Committee* - peregrine pharmaceuticals (PPHM)

Name (Connections)Board RelationshipsTitleKey Developments
Carlton Johnson Jr. 10 RelationshipsChairman, Chairman of Audit Committee, Member of Nominating Committee and Member of Compensation CommitteePeregrine Pharmaceuticals, Inc. Announces the Resignation of Jeffrey L. Masten as Vice President, Quality Effective February 20, 2014
01/23/14
Eric Swartz 7 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating CommitteePeregrine Pharmaceuticals, Inc. Approves Appointment of Carlton M. Johnson, Jr. as Director
10/18/13
David Pohl 18 RelationshipsIndependent Director, Chairman of Nominating Committee, Member of Audit Committee and Member of Compensation CommitteePeregrine Pharmaceuticals Inc. Appoints Mark R. Ziebell as Vice President and General Counsel
06/21/12

Advisory Committee* - peregrine pharmaceuticals (PPHM)

Name (Board Relationships)/Title Board Affiliations
Rolf Brekken 7 Relationships
Member of Scientific Resource Board of Oncology
No other board affiliations
Harold Dvorak 13 Relationships
Member of Scientific Resource Board of Oncology
No other board affiliations
Christopher Hughes 7 Relationships
Member of Scientific Resource Board of Oncology
No other board affiliations
Alan Schroit 7 Relationships
Member of Scientific Resource Board of Core Technologies
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPHM:US $1.15 USD 0.00

PPHM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aduro Biotech Inc $19.36 USD -1.25
GenVec Inc $2.53 USD +0.024
Inovio Pharmaceuticals Inc $7.49 USD -0.24
Progenics Pharmaceuticals Inc $7.33 USD -0.34
Vical Inc $0.59 USD +0.0002
View Industry Companies
 

Industry Analysis

PPHM

Industry Average

Valuation PPHM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.1x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEREGRINE PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.